Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets
Alvina I. Khamidullina, Yaroslav E. Abramenko, Alexandra V. Bruter, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1263-1263
Open Access | Times Cited: 19

Showing 19 citing articles:

ROS: A “booster” for chronic inflammation and tumor metastasis
Anqi Chen, Haifeng Huang, S. S. Fang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189175-189175
Closed Access | Times Cited: 18
Antisense mediated blockade of Dickkopf 1 attenuates tumor survival, metastases and bone damage in experimental osteosarcoma
Andrew Haskell, Simin Pan, Robert J. Reese, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
AZD6738 Attenuates LPS-Induced Corneal Inflammation and Fibrosis by Modulating Macrophage Function and Polarization
Longxiang Huang, Yiran Luo
Inflammation (2025)
Open Access
Critical Signalling Pathways Activating Cellular Senescence and Immortalization
D. S. Francis
(2025), pp. 59-83
Closed Access
LINC01235 Promotes Clonal Evolution through DNA Replication Licensing‐Induced Chromosomal Instability in Breast Cancer
Qi Zhang, Xuliren Wang, Zhibo Shao, et al.
Advanced Science (2025)
Open Access
CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells
Alvina I. Khamidullina, Margarita A. Yastrebova, Alexandra V. Bruter, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway
Longhai Li, Zhaoshuai Ji, Guangyun Li, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318776-e0318776
Open Access
Role of PARP Inhibitors: A New Hope for Breast Cancer Therapy
K De, Malabendu Jana, Bhabadeb Chowdhury, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2773-2773
Open Access
Circular RNA circ_0004470 accelerates the occurrence of lung cancer by promoting DNA damage and cell cycle arrest
Xueqi Li, Yufei Liu, Qiwen Zheng, et al.
Journal of Biological Chemistry (2025), pp. 108456-108456
Open Access
Integrating frontiers: a holistic, quantum and evolutionary approach to conquering cancer through systems biology and multidisciplinary synergy
Matheus Correia Casotti, Débora Dummer Meira, Aléxia Stefani Siqueira Zetum, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Combined SET7/9 and CDK4 inhibition act synergistically against osteosarcoma
Y. Shi, Zhonghao Wang, Yiming Shao, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 708, pp. 149808-149808
Closed Access | Times Cited: 2
Inhibitors and PROTACs of CDK2: challenges and opportunities
Yangjie Zeng, Xiaodong Ren, Pengyao Jin, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1125-1148
Closed Access | Times Cited: 2
CELL CYCLE DYSREGULATION IN CANCER
Antonino Glaviano, Samarendra Kumar Singh, E. Hui Clarissa Lee, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100030-100030
Closed Access | Times Cited: 2
AI in Pharma: Transforming Drug Discovery and Strategic Management with MYC-Modulating Compounds and BET Protein Inhibitors
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 3, pp. 334-336
Open Access | Times Cited: 1
Mixtures of Three Mortaparibs with Enhanced Anticancer, Anti-Migration, and Antistress Activities: Molecular Characterization in p53-Null Cancer Cells
Renu Wadhwa, Shiming Yang, Hazna Noor Meidinna, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2239-2239
Open Access | Times Cited: 1
Gynecologic Cancer InterGroup CA125 response has a high negative predictive value for CHK1 inhibitor RECIST response in recurrent ovarian cancer
Kristen R. Ibanez, Duncan Donohue, Tyler Malys, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Dissociation of the nuclear WWOX/TRAF2 switch renders UV/cold shock-mediated nuclear bubbling cell death at low temperatures
Szu-Jung Chen, Cheng‐Chang Tsai, Sing-Ru Lin, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Distinct Immune Landscape and Gene Expression Profiles in Breast Cancer: Young vs. Non-Young Patients
Zijun Zhu, Chen Gao, Yongxin Li, et al.
Research Square (Research Square) (2024)
Open Access
Toward Precision Oncology: The Role of TPD in Targeting CDK2 and Beyond
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 7, pp. 1004-1006
Open Access
Page 1

Scroll to top